Effect of rhIL-6 infusion on GH--&gt;IGF-I axis mediators in humans (Q46180021)

20 December 2017

title

Effect of rhIL-6 infusion on GH-->IGF-I axis mediators in humans (English)

1 reference

20 December 2017

author name string

Dan Nemet

1

1 reference

20 December 2017

Alon Eliakim

2

1 reference

20 December 2017

Frank Zaldivar

3

1 reference

20 December 2017

Dan M Cooper

4

1 reference

20 December 2017

publication date

13 July 2006

1 reference

20 December 2017

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

published in

1 reference

20 December 2017

volume

291

1 reference

20 December 2017

issue

6

1 reference

20 December 2017

page(s)

R1663-8

1 reference

20 December 2017

Invited Review: Autocrine/paracrine IGF-I and skeletal muscle adaptation

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

Exercise-induced changes in insulin-like growth factors and their low molecular weight binding protein in healthy subjects and patients with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

Ligand-mediated immunofunctional assay for quantitation of growth hormone-binding protein in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

Leptin and IGF-I levels in unconditioned male volunteers after short-term exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

Change in Muscle Strength Explains Accelerated Decline of Physical Function in Older Women With High Interleukin-6 Serum Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

IL-6-induced skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

Acquired growth hormone resistance in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

IL-1 receptor antagonist attenuates sepsis-induced alterations in the IGF system and protein synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

IL-6-overexpression brings about growth impairment potentially through a GH receptor defect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

The metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

New molecular mechanisms of GH resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

IL-6 stimulation of insulin-like growth factor binding protein (IGFBP)-1 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

Effect of exercise on cytokines and growth mediators in prepubertal children

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

Characterization of vectorial chloride transport pathways in the human pancreatic duct adenocarcinoma cell line HPAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

Prolonged exercise increases serum insulin-like growth factor-binding protein concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

Fitness, acute exercise, and anabolic and catabolic mediators in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

Interleukin-6 stimulates lipolysis and fat oxidation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

Growth hormone down-regulation of Interleukin-1beta and Interleukin-6 induced acute phase protein gene expression is associated with increased gene expression of suppressor of cytokine signal-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

Interleukin-6 production by contracting human skeletal muscle: autocrine regulation by IL-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00053.2006

10.1152/AJPREGU.00053.2006

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017